Sort   by:  
 Page size 
UnknownEvaluating diabetes-specific meal replacements for glycaemic control in overweight and obese patients with T2DM: a protocol for a randomised controlled trial.
Not available
S-EPMC12517022 | biostudies-literature
UnknownSeroprevalence of hepatitis B virus and hepatitis C virus infection among Malaysian population.
Not available
S-EPMC7713078 | biostudies-literature
UnknownFatty Acid Composition of Selected Street Foods Commonly Available in Malaysia.
Not available
S-EPMC10048182 | biostudies-literature
UnknownIntubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries.
Not available
S-EPMC7988368 | biostudies-literature
UnknownSurgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study.
Not available
S-EPMC5910057 | biostudies-literature
UnknownEffects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Not available
S-EPMC12274867 | biostudies-literature
UnknownEffects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
Not available
S-EPMC7615591 | biostudies-literature
UnknownImpact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
Not available
S-EPMC7618536 | biostudies-literature
UnknownLong-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7616743 | biostudies-literature
UnknownFrailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Not available
S-EPMC11390031 | biostudies-literature
Sort   by:  
 Page size